Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 19

1.

Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.

Margolskee E, Bao F, de Gonzalez AK, Moreira RK, Lagana S, Sireci AN, Sepulveda AR, Remotti H, Lefkowitch JH, Salomao M.

Diagn Pathol. 2016 Mar 9;11:27. doi: 10.1186/s13000-016-0475-5.

2.

Current Proceedings in the Molecular Dissection of Hepatocellular Adenomas: Review and Hands-on Guide for Diagnosis.

Goltz D, Fischer HP.

Int J Mol Sci. 2015 Sep 2;16(9):20994-1007. doi: 10.3390/ijms160920994. Review.

3.

Current concepts in the immunohistochemical evaluation of liver tumors.

Koehne de Gonzalez AK, Salomao MA, Lagana SM.

World J Hepatol. 2015 Jun 8;7(10):1403-11. doi: 10.4254/wjh.v7.i10.1403. Review.

4.

Imaging of hepatocellular carcinoma patient-derived xenografts using ⁸⁹Zr-labeled anti-glypican-3 monoclonal antibody.

Yang X, Liu H, Sun CK, Natarajan A, Hu X, Wang X, Allegretta M, Guttmann RD, Gambhir SS, Chua MS, Cheng Z, So SK.

Biomaterials. 2014 Aug;35(25):6964-71. doi: 10.1016/j.biomaterials.2014.04.089. Epub 2014 May 16.

5.

Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions.

Matkowskyj KA, Bai H, Liao J, Zhang W, Li H, Rao S, Omary R, Yang GY.

Hum Pathol. 2014 Apr;45(4):834-43. doi: 10.1016/j.humpath.2013.12.002. Epub 2013 Dec 18.

6.

Dysplastic nodules with glypican-3 positive immunostaining: a risk for early hepatocellular carcinoma.

Gong L, Wei LX, Ren P, Zhang WD, Liu XY, Han XJ, Yao L, Zhu SJ, Lan M, Li YH, Zhang W.

PLoS One. 2014 Jan 31;9(1):e87120. doi: 10.1371/journal.pone.0087120. eCollection 2014.

7.

Glypican-3 antibodies: a new therapeutic target for liver cancer.

Feng M, Ho M.

FEBS Lett. 2014 Jan 21;588(2):377-82. doi: 10.1016/j.febslet.2013.10.002. Epub 2013 Oct 15. Review.

8.

Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.

Yao S, Zhang J, Chen H, Sheng Y, Zhang X, Liu Z, Zhang C.

J Histochem Cytochem. 2013 Sep;61(9):639-48. doi: 10.1369/0022155413492771. Epub 2013 May 16.

9.

A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values.

Jin GZ, Dong H, Yu WL, Li Y, Lu XY, Yu H, Xian ZH, Dong W, Liu YK, Cong WM, Wu MC.

BMC Cancer. 2013 Mar 27;13:161. doi: 10.1186/1471-2407-13-161.

10.

Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy.

Chen IP, Ariizumi S, Nakano M, Yamamoto M.

J Gastroenterol. 2014 Jan;49(1):117-25. doi: 10.1007/s00535-013-0793-2. Epub 2013 Mar 27.

11.

Hepatocellular tumors: immunohistochemical analyses for classification and prognostication.

Lo RC, Ng IO.

Chin J Cancer Res. 2011 Dec;23(4):245-53. doi: 10.1007/s11670-011-0245-6.

12.

Novel ATP8B1 mutation in an adult male with progressive familial intrahepatic cholestasis.

Deng BC, Lv S, Cui W, Zhao R, Lu X, Wu J, Liu P.

World J Gastroenterol. 2012 Nov 28;18(44):6504-9. doi: 10.3748/wjg.v18.i44.6504.

13.

Validation of glypican-3-specific scFv isolated from paired display/secretory yeast display library.

Li Y, Siegel DL, Scholler N, Kaplan DE.

BMC Biotechnol. 2012 May 7;12:23. doi: 10.1186/1472-6750-12-23.

14.

Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver.

Levy M, Trivedi A, Zhang J, Miles L, Mattis AN, Kim GE, Lassman C, Anders RA, Misdraji J, Yerian LM, Xu H, Dhall D, Wang HL.

Hum Pathol. 2012 May;43(5):695-701. doi: 10.1016/j.humpath.2011.06.016. Epub 2011 Sep 19.

15.

Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.

Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng X, Qi X, Cao Y, Su M, Wang X, Xu LX, Yen Y, Liu P, Jia W.

Mol Cell Proteomics. 2011 Jul;10(7):M110.004945. doi: 10.1074/mcp.M110.004945. Epub 2011 Apr 25. Erratum in: Mol Cell Proteomics. 2011 Nov;10(11). doi:10.1074/mcp.A110.004945.

16.

Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.

Andreana L, Isgrò G, Pleguezuelo M, Germani G, Burroughs AK.

World J Hepatol. 2009 Oct 31;1(1):48-61. doi: 10.4254/wjh.v1.i1.48.

17.

Expression of glypican 3 in placental site trophoblastic tumor.

Ou-Yang RJ, Hui P, Yang XJ, Zynger DL.

Diagn Pathol. 2010 Sep 25;5:64. doi: 10.1186/1746-1596-5-64.

18.

Generation of functional CD8+ T cells by human dendritic cells expressing glypican-3 epitopes.

O'Beirne J, Farzaneh F, Harrison PM.

J Exp Clin Cancer Res. 2010 May 13;29:48. doi: 10.1186/1756-9966-29-48.

19.

Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms.

Kakar S, Chen X, Ho C, Burgart LJ, Adeyi O, Jain D, Sahai V, Ferrell LD.

Histopathology. 2009 Aug;55(2):197-205. doi: 10.1111/j.1365-2559.2009.03343.x.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk